SBC Medical Group Holdings Incorporated (SBC) Revenue History
Annual and quarterly revenue from 2022 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
SBC Revenue Growth
SBC Revenue Analysis (2022–2024)
As of May 8, 2026, SBC Medical Group Holdings Incorporated (SBC) generated trailing twelve-month (TTM) revenue of $178.5 million, reflecting significant decline in growth of -18.3% year-over-year. The most recent quarter (Q3 2025) recorded $43.4 million in revenue, down 0.0% sequentially.
Looking at the longer-term picture, SBC's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $205.4 million in 2024, representing a new all-time high.
When compared to Industrials sector peers including SKIN (-8.2% YoY), INMD (-4.5% YoY), and SSKN (-5.2% YoY), SBC has underperformed the peer group in terms of revenue growth. Compare SBC vs SKIN →
SBC Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| SBCCurrent | $178M | -18.3% | - | 34.2% | |
 SKIN | $301M | -8.2% | +20.4% | -6.9% | |
 INMD | $370M | -4.5% | +12.4% | 23.0% | |
 SSKN | $34M | -5.2% | +1.2% | -27.6% | |
 NVCR | $655M | +8.5% | +5.8% | -23.5% | |
 LASE | $3M | +177.0% | - | -189.3% |
SBC Historical Revenue Data (2022–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $205.4M | +6.1% | $156.1M | 76.0% | $70.3M | 34.2% |
| 2023 | $193.5M | +11.1% | $137.3M | 70.9% | $70.7M | 36.5% |
| 2022 | $174.2M | - | $114.8M | 65.9% | $20.1M | 11.6% |
See SBC's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs SBC Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare SBC vs SPIR
Side-by-side business, growth, and profitability comparison vs Spire Global, Inc..
Start ComparisonSBC — Frequently Asked Questions
Quick answers to the most common questions about buying SBC stock.
Is SBC's revenue growth accelerating or slowing?
SBC revenue declined -18.3% year-over-year, contrasting with the 5-year CAGR of N/A. TTM revenue fell to $178M. This reverses the prior growth trend.
What is SBC's long-term revenue growth rate?
SBC Medical Group Holdings Incorporated's 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of -18.3% is below this long-term average.
How is SBC's revenue distributed by segment?
SBC reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2022-2024 are available for download. Segment mix reveals concentration and diversification trends.